• Improved sensitivity because it includes TBRF Borreliae-specific antigens from multiple strains and species.
• Improved specificity because pure proteins are sprayed at specific positions on the blot.
• Superior at all stages of TBRF disease.
• Possible speciation of the individual Borrelia strains.
Positive: If two TBRF Borrelia specific bands are present
Indeterminate: If one TBRF Borrelia specific IgG band is present
The TBRF ImmunoBlot can result in a false negative early in the disease.
A negative TBRF ImmunoBlot does not exclude the possibility of infection with TBRF Borrelia. IGeneX interpretation is based on internal validation studies. The results of this test must be interpreted in relation to a patient’s clinical history, epidemiological data, stages of disease, clinical symptoms or other laboratory results. An Indeterminate result may have clinical significance. Therefore, we recommend testing with another method and/or retesting in 4-6 weeks.